TTT Consulting Ltd

Target to Treatment (TTT) Consulting Ltd is an independent consultancy that delivers expert advice and hands‑on services across the drug discovery‑to‑development continuum. Working with biotech firms, pharmaceutical companies and academic research groups, TTT helps turn early‑stage concepts into clinically‑validated candidates, guiding projects from target identification and candidate selection right through to Phase 2A proof‑of‑concept.

The team’s core specialities lie in fibrosis, inflammation and auto‑immunity, and they have proven capability with both oral and inhaled small‑molecule programmes as well as a range of biological modalities. Services are fully bespoke – from one‑off feasibility studies to ongoing support of internal project teams – and cover every key step of the pipeline, including target validation, optimisation, toxicology, formulation, biomarker strategy, clinical trial design and regulatory scientific advice. Their deep experience in biomarker development, patient stratification and translational science enables clients to de‑risk programmes and accelerate decision‑making.

TTT’s collaborative approach, backed by a network of complementary partner companies, ensures that even the most complex projects receive flexible, science‑driven solutions tailored to each client’s unique goals. Get in touch for an initial discussion and discover how TTT can help you move from target to treatment.